Cyanosis epidemiology and demographics: Difference between revisions

	Cyanosis Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cyanosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cyanosis epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cyanosis epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cyanosis epidemiology and demographics
CDC on Cyanosis epidemiology and demographics
Cyanosis epidemiology and demographics in the news
Blogs on Cyanosis epidemiology and demographics
Directions to Hospitals Treating Cyanosis
Risk calculators and risk factors for Cyanosis epidemiology and demographics

VisualWikitext

Latest revision as of 04:08, 26 December 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]

Overview

The prevalence of congenital heart disease is approximately 1000 per 100,000 individuals worldwide. Data about the incidence of cyanotic congenital heart disease is inadequate. Congenital cyanotic heart disease is more commonly observed among neonates. Congenital cyanotic heart disease affects men and women equally. There is no racial predilection for cyanotic congenital heart disease.

Epidemiology and Demographics

The prevalence of congenital heart disease is approximately 1000 per 100,000 individuals worldwide.^[1]
Data about the incidence of cyanotic congenital heart disease is inadequate.

Age

Congenital cyanotic heart disease is more commonly observed among neonates.

Gender

Congenital cyanotic heart disease affects men and women equally.

Race

There is no racial predilection for cyanotic congenital heart disease.

References

↑ Stout, Karen K.; Daniels, Curt J.; Aboulhosn, Jamil A.; Bozkurt, Biykem; Broberg, Craig S.; Colman, Jack M.; Crumb, Stephen R.; Dearani, Joseph A.; Fuller, Stephanie; Gurvitz, Michelle; Khairy, Paul; Landzberg, Michael J.; Saidi, Arwa; Valente, Anne Marie; Van Hare, George F. (2019). "2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Circulation. 139 (14). doi:10.1161/CIR.0000000000000603. ISSN 0009-7322.

[StoutDaniels2019-1] Stout, Karen K.; Daniels, Curt J.; Aboulhosn, Jamil A.; Bozkurt, Biykem; Broberg, Craig S.; Colman, Jack M.; Crumb, Stephen R.; Dearani, Joseph A.; Fuller, Stephanie; Gurvitz, Michelle; Khairy, Paul; Landzberg, Michael J.; Saidi, Arwa; Valente, Anne Marie; Van Hare, George F. (2019). "2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Circulation. 139 (14). doi:10.1161/CIR.0000000000000603. ISSN 0009-7322.

[1]

@@ Line 2: / Line 2: @@
 {{Cyanosis}}
-{{CMG}}; {{AE}}
+{{CMG}}; {{AE}} {{Sara.Zand}}
 ==Overview==
+The prevalence of congenital heart disease is approximately 1000 per 100,000 individuals worldwide. Data about the incidence of [[cyanotic]] [[congenital heart disease]] is inadequate. [[Congenital cyanotic heart disease]] is more commonly observed among neonates. [[Congenital cyanotic heart disease]] affects men and women equally. There is no racial predilection for [[cyanotic congenital heart disease]].
 ==Epidemiology and Demographics==
-===Incidence===
+*The prevalence of [[congenital heart disease]] is approximately 1000 per 100,000 individuals worldwide.<ref name="StoutDaniels2019">{{cite journal|last1=Stout|first1=Karen K.|last2=Daniels|first2=Curt J.|last3=Aboulhosn|first3=Jamil A.|last4=Bozkurt|first4=Biykem|last5=Broberg|first5=Craig S.|last6=Colman|first6=Jack M.|last7=Crumb|first7=Stephen R.|last8=Dearani|first8=Joseph A.|last9=Fuller|first9=Stephanie|last10=Gurvitz|first10=Michelle|last11=Khairy|first11=Paul|last12=Landzberg|first12=Michael J.|last13=Saidi|first13=Arwa|last14=Valente|first14=Anne Marie|last15=Van Hare|first15=George F.|title=2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines|journal=Circulation|volume=139|issue=14|year=2019|issn=0009-7322|doi=10.1161/CIR.0000000000000603}}</ref>
-*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
+* Data about the incidence of [[cyanotic congenital heart disease]] is inadequate.
-*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
-===Prevalence===
-*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
-*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
-*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
-===Case-fatality rate/Mortality rate===
-*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
-*The case-fatality rate/mortality rate of [disease name] is approximately [number range].
 ===Age===
-*Patients of all age groups may develop [disease name].
+*[[Congenital cyanotic heart disease]] is more commonly observed among neonates.
-*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
-*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
-*[Chronic disease name] is usually first diagnosed among [age group].
-*[Acute disease name] commonly affects [age group].
-===Race===
-*There is no racial predilection to [disease name].
-*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
 ===Gender===
-*[Disease name] affects men and women equally.
+*[[Congenital cyanotic heart disease]] affects men and women equally.
-*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
-===Region===
-*The majority of [disease name] cases are reported in [geographical region].
-*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
+===Race===
+*There is no racial predilection for [[cyanotic]] [[congenital heart disease]].
-===Developed Countries===
-===Developing Countries===
 ==References==
 {{Reflist|2}}
+[[Category:Primary care]]
-{{WH}}
-{{WS}}
-[[Category: (name of the system)]]